SARAH WOODFIELD to Drug Resistance, Neoplasm
This is a "connection" page, showing publications SARAH WOODFIELD has written about Drug Resistance, Neoplasm.
Connection Strength
0.071
-
Phase 1 study of NEDD8 activating enzyme inhibitor pevonedistat in combination with chemotherapy in pediatric patients with recurrent or refractory solid tumors (ADVL1615). Eur J Cancer. 2024 Sep; 209:114241.
Score: 0.042
-
Inhibition of Ubiquitin-Specific Protease 14 Suppresses Cell Proliferation and Synergizes with Chemotherapeutic Agents in Neuroblastoma. Mol Cancer Ther. 2019 06; 18(6):1045-1056.
Score: 0.029